nidНефрология и диализNephrology and Dialysis1680-44222618-9801Российское диализное обществоnid-3118Research ArticleОРИГИНАЛЬНЫЕ СТАТЬИORIGINAL ARTICLESИнтегрированный подход к заместительной почечной терапииIntegrative approach to renal replacement therapyАндрусевА. М.AndrusevA. N.noemail@neicon.ruТитоваН. Л.TitovaN. L.noemail@neicon.ruБикбовБ. Т.BikbovB. T.noemail@neicon.ruТомилинаН. А.TomilinaN. A.noemail@neicon.ruМосковский городской нефрологический центр, городская клиническая больница № 52Russian Federation20032706202552134140Copyright © Андрусев А.М., Титова Н.Л., Бикбов Б.Т., Томилина Н.А., 20252025Андрусев А.М., Титова Н.Л., Бикбов Б.Т., Томилина Н.А.Andrusev A.N., Titova N.L., Bikbov B.T., Tomilina N.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.nephro.ru/jour/article/view/3118

Проанализирован опыт лечения 298 пациентов, находившихся на перитонеальном диализе (ПД) в Московском городском нефрологическом центре (ГКБ № 52) в 1995-2002 гг., и литературные данные. ПД является важной составляющей заместительной почечной терапии (ЗПТ). В течение первых 5 лет лечения его эффективность не уступает эффективности гемодиализа. Современная ЗПТ предполагает интеграцию разных методов лечения. При этом ПД следует рассматривать как оптимальный метод для начала ЗПТ, после которого больным может быть выполнена трансплантация почки или лечение гемодиализом. С другой стороны, пациенты гемодиализа при отсутствии возможности поддержания адекватного сосудистого доступа или при серьезной, гемодинамически значимой сердечной патологии могут быть переведены на перитонеальный диализ. Такой комбинированный подход позволяет значительно продлить жизнь пациента с терминальной стадией хронической почечной недостаточности.

Experience gained during the treatment of 298 patients on peritoneal dialysis in Moscow Nephrological centre in the years 1995-2002 is analysed and compared with published reports. Peritoneal dialysis is an important component of renal replacement therapy. For first 5 years of therapy its efficiency is as high as that of hemodialysis. Modern renal replacement therapy involves a combination of different methods. Among them peritoneal dialysis is an optimal primary therapy which can be later followed by kidney transplantation or hemodialysis. Alternatively, hemodialysis patients with failed vascular access or significant cardiac failure could be effectively treated with peritoneal dialysis. Such combined approach enables us to increase significantly life expectation of patient with end stage kidney failure.

заместительная почечная терапияперитонеальный диализReferencesBerlanga J.R., Marron B., Reyero A., Caramelo C., Oritiz A. Peritoneal dialysis retardation of progression of advanced renal failure. Perit Dial Int 2002; 22: 239-242.Berlanga J.R., Marron B., Reyero A., Caramelo C., Oritiz A. Peritoneal dialysis retardation of progression of advanced renal failure. Perit Dial Int 2002; 22: 239-242.Davies S.J., Phillips L., Griffits A.M., Russell L.H., Naish P.F., Russell J.I. What realy happens to people on long-term peritoneal dialysis? Kidney Int 1998; 54: 2207-2217.Davies S.J., Phillips L., Griffits A.M., Russell L.H., Naish P.F., Russell J.I. What realy happens to people on long-term peritoneal dialysis? Kidney Int 1998; 54: 2207-2217.Davies S.J., Phillips L., Naish P.F., Russel G.I. Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. J Am Soc Nephrol 2001; 12: 1046-1051.Davies S.J., Phillips L., Naish P.F., Russel G.I. Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. J Am Soc Nephrol 2001; 12: 1046-1051.Fenton S.S.A., Shaubel D.E., Desmeules W., Morrison S.I., Moa Y., Copleston P. et al. Heamodialysis versus peritoneal dialysis: a comparison of adjusted mortality rates. J Am Soc Nephrol 1997; 30: 334-342.Fenton S.S.A., Shaubel D.E., Desmeules W., Morrison S.I., Moa Y., Copleston P. et al. Heamodialysis versus peritoneal dialysis: a comparison of adjusted mortality rates. J Am Soc Nephrol 1997; 30: 334-342.Gokal R. Peritoneal dalysis in the 21-st century: An analysis of current problems and future developments. J Am Soc Nephrol 2002; 13: 104-116.Gokal R. Peritoneal dalysis in the 21-st century: An analysis of current problems and future developments. J Am Soc Nephrol 2002; 13: 104-116.Gokal R. History of peritoneal dalysis in Gokal R., Khanna R., Krediet R.T., Nolph K.D. (eds). Textbook of Peritoneal Dialyasis (ed 2). Dordecht/Boston/London: Kluwer Academic Publishers 2000.Gokal R. History of peritoneal dalysis in Gokal R., Khanna R., Krediet R.T., Nolph K.D. (eds). Textbook of Peritoneal Dialyasis (ed 2). Dordecht/Boston/London: Kluwer Academic Publishers 2000.Ha H., Lee H.B. Effect of high glucose on peritoneal mesothelial cell biology. Perit Dial Int 2002; 20; Suppl 2: 15-18.Ha H., Lee H.B. Effect of high glucose on peritoneal mesothelial cell biology. Perit Dial Int 2002; 20; Suppl 2: 15-18.Krediet RT. Peritoneal anatomy and physiology during peritoneal dialysis in Jacobs C., Kjellstrand C.M., Koch K.M., Winchester J.F. (eds). Replacement of Renal Function by Dialysis (ed 4). Dordecht/Boston/London: Kluwer Academic Publishers 1996.Krediet RT. Peritoneal anatomy and physiology during peritoneal dialysis in Jacobs C., Kjellstrand C.M., Koch K.M., Winchester J.F. (eds). Replacement of Renal Function by Dialysis (ed 4). Dordecht/Boston/London: Kluwer Academic Publishers 1996.Kim M., Lofthouse J., Flessner M.F. Blood flow limitations of solute transport across the visceral peritoneum. J Am Soc Nephrol 1997; 8: 1946-1950.Kim M., Lofthouse J., Flessner M.F. Blood flow limitations of solute transport across the visceral peritoneum. J Am Soc Nephrol 1997; 8: 1946-1950.Kawaguchi Y. Peritoneal dialysis as long-term treatment: comparison of technique survival between Asian and Western populations. Perit Dial Int 1999; 19; Suppl 2: 327-328.Kawaguchi Y. Peritoneal dialysis as long-term treatment: comparison of technique survival between Asian and Western populations. Perit Dial Int 1999; 19; Suppl 2: 327-328.Krediet R.T., Zweers M.M., van der Wal A.C., Struijk D.G. Neoangiogenesis in the peritoneal membrane. Perit Dial Int 2000; 20; Suppl 2: 19-25.Krediet R.T., Zweers M.M., van der Wal A.C., Struijk D.G. Neoangiogenesis in the peritoneal membrane. Perit Dial Int 2000; 20; Suppl 2: 19-25.Lori J.-H. Peritoneal Dialysis: a history. Contemporary Dialysis and Nephrology, 20th Issue 1999: 19-21.Lori J.-H. Peritoneal Dialysis: a history. Contemporary Dialysis and Nephrology, 20th Issue 1999: 19-21.Lameire N., Biesen W.V., Vanholder R. The role of peritoneal dialysis as first modality in an integrative approach to patients with end-stage renal disease. Perit Dial Int 2000; 20: 134-141.Lameire N., Biesen W.V., Vanholder R. The role of peritoneal dialysis as first modality in an integrative approach to patients with end-stage renal disease. Perit Dial Int 2000; 20: 134-141.Mehrotra R., Nolph K.D. Current status of peritoneal dalysis in Gokal R., Khanna R., Krediet R.T., Nolph K.D. (eds). Textbook of Peritoneal Dialyasis (ed 2). Dordecht/Boston/London: Kluwer Academic Publishers 2001.Mehrotra R., Nolph K.D. Current status of peritoneal dalysis in Gokal R., Khanna R., Krediet R.T., Nolph K.D. (eds). Textbook of Peritoneal Dialyasis (ed 2). Dordecht/Boston/London: Kluwer Academic Publishers 2001.Nolph K.D. 1975 to 1984 - an impotrant decade for peritoneal dialysis: memories with personal anecdotes. Perit Dial Int 2002; 22: 608-613.Nolph K.D. 1975 to 1984 - an impotrant decade for peritoneal dialysis: memories with personal anecdotes. Perit Dial Int 2002; 22: 608-613.Schaubel D.E., Blake P.G. Fenton SSA: trends in CAPD technique failure. Canada, 1981-1997. Perit Dial Int 2001; 21: 365-371.Schaubel D.E., Blake P.G. Fenton SSA: trends in CAPD technique failure. Canada, 1981-1997. Perit Dial Int 2001; 21: 365-371.Van Biesen W., Wiedemann M., Lameire N. End-stage renal disease treatment: a European perspective. J Am Soc Nephrol 1999; 9: 1-8.Van Biesen W., Wiedemann M., Lameire N. End-stage renal disease treatment: a European perspective. J Am Soc Nephrol 1999; 9: 1-8.Van Olden R.W., Krediet R.T., Struijk D.G., Arisz L. Measurement of residual renal function in patients treated with continuous peritoneal dialysis. J Am Soc Nephrol 7: 745-748, 1996.Van Olden R.W., Krediet R.T., Struijk D.G., Arisz L. Measurement of residual renal function in patients treated with continuous peritoneal dialysis. J Am Soc Nephrol 7: 745-748, 1996.Wai-Kei L. What factors contribute to differences in the practice of peritoneal dialysis between Asian countries and the West? Perit Dial Int 2002; 22: 249-257.Wai-Kei L. What factors contribute to differences in the practice of peritoneal dialysis between Asian countries and the West? Perit Dial Int 2002; 22: 249-257.Williams J.D., Craig K.J., Topley N., Von Ruhland C., Fallon M., Newman G.R., Mackenzie R.K. Williams GT: Morphologic changes in the peritoneal membrane of patients with renal disease J Am Soc Nephrol 2002; 13: 470-479.Williams J.D., Craig K.J., Topley N., Von Ruhland C., Fallon M., Newman G.R., Mackenzie R.K. Williams GT: Morphologic changes in the peritoneal membrane of patients with renal disease J Am Soc Nephrol 2002; 13: 470-479.Witowski J., Jorres A. Glucose degradation products: relationship with cell Damage. Perit Dial Int 2000; 20; Suppl 2: 31-36.Witowski J., Jorres A. Glucose degradation products: relationship with cell Damage. Perit Dial Int 2000; 20; Suppl 2: 31-36.

The authors declare that there are no conflicts of interest present.